Diabetes
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Unlock global diabetes market insights. Get critical pharma intelligence on R&D, regulatory approvals, and investment opportunities for diabetes treatments.
Showing 1–3 of 3 articles
Quick answer
NovaPharmaNews Diabetes hub for NMPA covers 3 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
MannKind's Pediatric Expansion: A New Era for Afrezza
Ascletis Pharma to Present Diabetes Drug Data at American Diabetes Association 2026 Scientific Sessions
Growth of Generics Market India: Impact of CDSCO Policy Changes on Pricing
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.